tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Derek Archila, 172 are a BUY (65.4%), 87 are a HOLD (33.08%), 4 are a SELL (1.52%).
Analyst Derek Archila, currently employed at WELLS FARGO, carries an average stock price target met ratio of 50.41% that have a potential upside of 41.02% achieved within 146 days.
Derek Archila’s has documented 511 price targets and ratings displayed on 46 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on KYMR, Kymera Therapeutics at 26-Jun-2025.
Analyst best performing recommendations are on ARNA (ARENA PHARMACEUTICALS).
The best stock recommendation documented was for ARNA (ARENA PHARMACEUTICALS) at 12/10/2021. The price target of $71 was fulfilled within 3 days with a profit of $21.06 (42.17%) receiving and performance score of 140.57.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$18
4 years 10 months 2 days ago
(01-Sep-2020)
3/3 (100%)
$3.19 (21.54%)
78
Hold
$60
4 years 10 months 2 days ago
(31-Aug-2020)
0/19 (0%)
$41.31 (221.03%)
Hold
$34.5
$0.01 (0.03%)
$66
4 years 10 months 2 days ago
(31-Aug-2020)
1/8 (12.5%)
$0.28 (0.82%)
39
Hold
$34.5
$0.01 (0.03%)
$14
4 years 10 months 2 days ago
(31-Aug-2020)
7/7 (100%)
$0.28 (0.82%)
105
Hold
$35
$0.51 (1.48%)
$24
4 years 10 months 2 days ago
(31-Aug-2020)
7/17 (41.18%)
$0.78 (2.28%)
376
Which stock is Derek Archila is most bullish on?
Which stock is Derek Archila is most reserved on?
What Year was the first public recommendation made by Derek Archila?
